$CYTK Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CYTOKINETICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in CYTOKINETICS INC. Get notifications about new insider transactions in CYTOKINETICS INC for free.
Page: < prev 1 ... 6 7 8 9 10 11 12 13 14 ... 17 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30 2009 | CYTK | CYTOKINETICS INC | Sabry James H | Executive Chairman | Sell | S | 2.82 | 200 | 564 | 63,146 | 63.3 K to 63.1 K (-0.32 %) |
| Jun 30 2009 | CYTK | CYTOKINETICS INC | Sabry James H | Executive Chairman | Sell | S | 2.81 | 2,663 | 7,483 | 63,346 | 66 K to 63.3 K (-4.03 %) |
| Jun 30 2009 | CYTK | CYTOKINETICS INC | Sabry James H | Executive Chairman | Sell | S | 2.80 | 2,041 | 5,715 | 66,009 | 68.1 K to 66 K (-3.00 %) |
| Jun 30 2009 | CYTK | CYTOKINETICS INC | Sabry James H | Executive Chairman | Sell | S | 2.80 | 200 | 560 | 68,050 | 68.3 K to 68.1 K (-0.29 %) |
| Jun 30 2009 | CYTK | CYTOKINETICS INC | Sabry James H | Executive Chairman | Sell | S | 2.79 | 1,300 | 3,627 | 68,250 | 69.6 K to 68.3 K (-1.87 %) |
| Jun 30 2009 | CYTK | CYTOKINETICS INC | Sabry James H | Executive Chairman | Sell | S | 2.84 | 800 | 2,272 | 69,550 | 70.4 K to 69.6 K (-1.14 %) |
| Jun 30 2009 | CYTK | CYTOKINETICS INC | Sabry James H | Executive Chairman | Sell | S | 2.83 | 10,600 | 29,998 | 70,350 | 81 K to 70.4 K (-13.09 %) |
| Jun 30 2009 | CYTK | CYTOKINETICS INC | Sabry James H | Executive Chairman | Sell | S | 2.84 | 8,300 | 23,531 | 80,950 | 89.3 K to 81 K (-9.30 %) |
| Jun 30 2009 | CYTK | CYTOKINETICS INC | Sabry James H | Executive Chairman | Sell | S | 2.85 | 300 | 855 | 89,250 | 89.6 K to 89.3 K (-0.34 %) |
| Jun 23 2009 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Option Exercise | M | 1.20 | 1,000 | 1,200 | 23,333 | |
| Jun 23 2009 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Sell | S | 2.74 | 1,000 | 2,740 | 22,460 | 23.5 K to 22.5 K (-4.26 %) |
| Jun 23 2009 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Buy | M | 1.20 | 1,000 | 1,200 | 23,460 | 22.5 K to 23.5 K (+4.45 %) |
| Jun 10 2009 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Option Exercise | M | 1.20 | 1,000 | 1,200 | 24,333 | |
| Jun 10 2009 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Sell | S | 2.97 | 1,000 | 2,970 | 22,460 | 23.5 K to 22.5 K (-4.26 %) |
| Jun 10 2009 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Buy | M | 1.20 | 1,000 | 1,200 | 23,460 | 22.5 K to 23.5 K (+4.45 %) |
| Jun 08 2009 | CYTK | CYTOKINETICS INC | Sabry James H | Executive Chairman | Sell | S | 2.91 | 100 | 291 | 89,550 | 89.7 K to 89.6 K (-0.11 %) |
| Jun 08 2009 | CYTK | CYTOKINETICS INC | Sabry James H | Executive Chairman | Sell | S | 2.90 | 1,108 | 3,213 | 89,650 | 90.8 K to 89.7 K (-1.22 %) |
| Jun 08 2009 | CYTK | CYTOKINETICS INC | Sabry James H | Executive Chairman | Sell | S | 2.89 | 3,292 | 9,514 | 90,758 | 94.1 K to 90.8 K (-3.50 %) |
| Jun 08 2009 | CYTK | CYTOKINETICS INC | Sabry James H | Executive Chairman | Sell | S | 2.88 | 6,900 | 19,872 | 94,050 | 101 K to 94.1 K (-6.84 %) |
| Jun 08 2009 | CYTK | CYTOKINETICS INC | Sabry James H | Executive Chairman | Sell | S | 2.87 | 3,300 | 9,471 | 100,950 | 104.3 K to 101 K (-3.17 %) |
| Jun 08 2009 | CYTK | CYTOKINETICS INC | Sabry James H | Executive Chairman | Sell | S | 2.87 | 267 | 766 | 104,250 | 104.5 K to 104.3 K (-0.26 %) |
| Jun 08 2009 | CYTK | CYTOKINETICS INC | Sabry James H | Executive Chairman | Sell | S | 2.86 | 4,133 | 11,820 | 104,517 | 108.7 K to 104.5 K (-3.80 %) |
| Jun 08 2009 | CYTK | CYTOKINETICS INC | Sabry James H | Executive Chairman | Sell | S | 2.85 | 5,200 | 14,820 | 108,650 | 113.9 K to 108.7 K (-4.57 %) |
| Jun 08 2009 | CYTK | CYTOKINETICS INC | Sabry James H | Executive Chairman | Sell | S | 2.84 | 1,900 | 5,396 | 113,850 | 115.8 K to 113.9 K (-1.64 %) |
| Jun 08 2009 | CYTK | CYTOKINETICS INC | Sabry James H | Executive Chairman | Sell | S | 2.83 | 3,500 | 9,905 | 115,750 | 119.3 K to 115.8 K (-2.94 %) |
| Jun 08 2009 | CYTK | CYTOKINETICS INC | Sabry James H | Executive Chairman | Sell | S | 2.82 | 100 | 282 | 119,250 | 119.4 K to 119.3 K (-0.08 %) |
| Jun 08 2009 | CYTK | CYTOKINETICS INC | Sabry James H | Executive Chairman | Sell | S | 2.93 | 1,309 | 3,835 | 119,350 | 120.7 K to 119.4 K (-1.08 %) |
| Jun 08 2009 | CYTK | CYTOKINETICS INC | Sabry James H | Executive Chairman | Sell | S | 2.92 | 2,626 | 7,668 | 120,659 | 123.3 K to 120.7 K (-2.13 %) |
| Jun 08 2009 | CYTK | CYTOKINETICS INC | Sabry James H | Executive Chairman | Sell | S | 2.91 | 3,065 | 8,919 | 123,285 | 126.4 K to 123.3 K (-2.43 %) |
| Jun 08 2009 | CYTK | CYTOKINETICS INC | Sabry James H | Executive Chairman | Sell | S | 2.90 | 1,100 | 3,190 | 126,350 | 127.5 K to 126.4 K (-0.86 %) |
| Jun 08 2009 | CYTK | CYTOKINETICS INC | Sabry James H | Executive Chairman | Sell | S | 2.89 | 1,500 | 4,335 | 127,450 | 129 K to 127.5 K (-1.16 %) |
| Jun 08 2009 | CYTK | CYTOKINETICS INC | Sabry James H | Executive Chairman | Sell | S | 2.88 | 600 | 1,728 | 128,950 | 129.6 K to 129 K (-0.46 %) |
| Jun 08 2009 | CYTK | CYTOKINETICS INC | Sabry James H | Executive Chairman | Sell | S | 2.87 | 400 | 1,148 | 129,550 | 130 K to 129.6 K (-0.31 %) |
| Jun 08 2009 | CYTK | CYTOKINETICS INC | Sabry James H | Executive Chairman | Sell | S | 2.86 | 1,356 | 3,878 | 129,950 | 131.3 K to 130 K (-1.03 %) |
| Jun 08 2009 | CYTK | CYTOKINETICS INC | Sabry James H | Executive Chairman | Sell | S | 2.85 | 3,400 | 9,690 | 131,306 | 134.7 K to 131.3 K (-2.52 %) |
| Jun 08 2009 | CYTK | CYTOKINETICS INC | Sabry James H | Executive Chairman | Sell | S | 2.84 | 4,638 | 13,172 | 134,706 | 139.3 K to 134.7 K (-3.33 %) |
| Jun 08 2009 | CYTK | CYTOKINETICS INC | Sabry James H | Executive Chairman | Sell | S | 2.84 | 200 | 568 | 139,344 | 139.5 K to 139.3 K (-0.14 %) |
| Jun 08 2009 | CYTK | CYTOKINETICS INC | Sabry James H | Executive Chairman | Sell | S | 2.83 | 4,062 | 11,495 | 139,544 | 143.6 K to 139.5 K (-2.83 %) |
| Jun 08 2009 | CYTK | CYTOKINETICS INC | Sabry James H | Executive Chairman | Sell | S | 2.82 | 3,600 | 10,152 | 143,606 | 147.2 K to 143.6 K (-2.45 %) |
| Jun 08 2009 | CYTK | CYTOKINETICS INC | Sabry James H | Executive Chairman | Sell | S | 2.81 | 1,300 | 3,653 | 147,206 | 148.5 K to 147.2 K (-0.88 %) |
| Jun 08 2009 | CYTK | CYTOKINETICS INC | Sabry James H | Executive Chairman | Sell | S | 2.80 | 1,044 | 2,923 | 148,506 | 149.6 K to 148.5 K (-0.70 %) |
| May 26 2009 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Option Exercise | M | 1.20 | 1,000 | 1,200 | 25,333 | |
| May 26 2009 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Sell | S | 2.00 | 1,000 | 2,000 | 22,460 | 23.5 K to 22.5 K (-4.26 %) |
| May 26 2009 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Buy | M | 1.20 | 1,000 | 1,200 | 23,460 | 22.5 K to 23.5 K (+4.45 %) |
| May 22 2009 | CYTK | CYTOKINETICS INC | DOW STEPHEN M | Director | Option Exercise | A | 1.85 | 15,000 | 27,750 | 15,000 | |
| May 22 2009 | CYTK | CYTOKINETICS INC | SPUDICH JAMES A | Director | Option Exercise | A | 1.85 | 15,000 | 27,750 | 15,000 | |
| May 22 2009 | CYTK | CYTOKINETICS INC | MCDADE MARK | Director | Option Exercise | A | 1.85 | 15,000 | 27,750 | 15,000 | |
| May 22 2009 | CYTK | CYTOKINETICS INC | HENDERSON JOHN T | Director | Option Exercise | A | 1.85 | 15,000 | 27,750 | 15,000 | |
| May 22 2009 | CYTK | CYTOKINETICS INC | GILBERT DENISE | Director | Option Exercise | A | 1.85 | 15,000 | 27,750 | 15,000 | |
| May 22 2009 | CYTK | CYTOKINETICS INC | SCHMERTZLER MICHAEL | Director | Option Exercise | A | 1.85 | 15,000 | 27,750 | 15,000 | |
| May 22 2009 | CYTK | CYTOKINETICS INC | SCHMERTZLER MICHAEL | Director | Option Exercise | P | 2.75 | 761,420 | 2,093,905 | 761,420 | |
| May 22 2009 | CYTK | CYTOKINETICS INC | SCHMERTZLER MICHAEL | Director | Buy | P | 1.97 | 1,522,840 | 2,999,995 | 5,389,208 | 3.9 M to 5.4 M (+39.39 %) |
| May 21 2009 | CYTK | CYTOKINETICS INC | HEIDRICH A GRANT III | Director | Option Exercise | A | 1.85 | 15,000 | 27,750 | 15,000 | |
| May 19 2009 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Option Exercise | M | 1.20 | 1,000 | 1,200 | 26,333 | |
| May 19 2009 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Sell | S | 2.00 | 1,000 | 2,000 | 22,460 | 23.5 K to 22.5 K (-4.26 %) |
| May 19 2009 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Buy | M | 1.20 | 1,000 | 1,200 | 23,460 | 22.5 K to 23.5 K (+4.45 %) |
| May 08 2009 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Option Exercise | M | 1.20 | 1,000 | 1,200 | 27,333 | |
| May 08 2009 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Sell | S | 2.00 | 1,000 | 2,000 | 22,460 | 23.5 K to 22.5 K (-4.26 %) |
| May 08 2009 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Buy | M | 1.20 | 1,000 | 1,200 | 23,460 | 22.5 K to 23.5 K (+4.45 %) |
| May 05 2009 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Option Exercise | M | 1.20 | 4,676 | 5,611 | 28,333 | |
| May 05 2009 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Sell | S | 2.00 | 4,600 | 9,200 | 22,460 | 27.1 K to 22.5 K (-17.00 %) |
| May 05 2009 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Sell | S | 2.01 | 76 | 153 | 27,060 | 27.1 K to 27.1 K (-0.28 %) |
| May 05 2009 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Buy | M | 1.20 | 4,676 | 5,611 | 27,136 | 22.5 K to 27.1 K (+20.82 %) |
| Apr 28 2009 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Option Exercise | M | 1.20 | 324 | 389 | 33,009 | |
| Apr 28 2009 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Sell | S | 2.00 | 324 | 648 | 22,460 | 22.8 K to 22.5 K (-1.42 %) |
| Apr 28 2009 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Buy | M | 1.20 | 324 | 389 | 22,784 | 22.5 K to 22.8 K (+1.44 %) |
| Apr 23 2009 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Option Exercise | M | 1.20 | 25,200 | 30,240 | 33,333 | |
| Apr 23 2009 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Option Exercise | M | 1.20 | 2,800 | 3,360 | 58,533 | |
| Apr 23 2009 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Sell | S | 2.00 | 25,200 | 50,400 | 22,460 | 47.7 K to 22.5 K (-52.87 %) |
| Apr 23 2009 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Buy | M | 1.20 | 25,200 | 30,240 | 47,660 | 22.5 K to 47.7 K (+112.20 %) |
| Apr 23 2009 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Sell | S | 2.00 | 2,800 | 5,600 | 22,460 | 25.3 K to 22.5 K (-11.08 %) |
| Apr 23 2009 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Buy | M | 1.20 | 2,800 | 3,360 | 25,260 | 22.5 K to 25.3 K (+12.47 %) |
| Apr 03 2009 | CYTK | CYTOKINETICS INC | DOW STEPHEN M | Director | Option Exercise | A | 1.75 | 10,714 | 18,750 | 10,714 | |
| Apr 02 2009 | CYTK | CYTOKINETICS INC | HENDERSON JOHN T | Director | Option Exercise | A | 1.75 | 21,428 | 37,499 | 21,428 | |
| Apr 01 2009 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Option Exercise | M | 1.20 | 2,000 | 2,400 | 61,333 | |
| Apr 01 2009 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Sell | S | 2.00 | 2,000 | 4,000 | 22,460 | 24.5 K to 22.5 K (-8.18 %) |
| Apr 01 2009 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Buy | M | 1.20 | 2,000 | 2,400 | 24,460 | 22.5 K to 24.5 K (+8.90 %) |
| Mar 18 2009 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Option Exercise | M | 0.58 | 4,538 | 2,632 | 12 | |
| Mar 18 2009 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Option Exercise | M | 0.58 | 962 | 558 | 4,550 | |
| Mar 18 2009 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Sell | S | 2.00 | 4,538 | 9,076 | 22,460 | 27 K to 22.5 K (-16.81 %) |
| Mar 18 2009 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Buy | M | 0.58 | 4,538 | 2,632 | 26,998 | 22.5 K to 27 K (+20.20 %) |
| Mar 18 2009 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Sell | S | 2.00 | 962 | 1,924 | 22,460 | 23.4 K to 22.5 K (-4.11 %) |
| Mar 18 2009 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Buy | M | 0.58 | 962 | 558 | 23,422 | 22.5 K to 23.4 K (+4.28 %) |
| Mar 27 2009 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Option Exercise | M | 1.20 | 20,000 | 24,000 | 63,333 | |
| Mar 27 2009 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Sell | S | 2.00 | 20,000 | 40,000 | 22,460 | 42.5 K to 22.5 K (-47.10 %) |
| Mar 27 2009 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Buy | M | 1.20 | 20,000 | 24,000 | 42,460 | 22.5 K to 42.5 K (+89.05 %) |
| Mar 03 2009 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 1.61 | 100 | 161 | 59,500 | 59.6 K to 59.5 K (-0.17 %) |
| Mar 03 2009 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 1.58 | 100 | 158 | 59,600 | 59.7 K to 59.6 K (-0.17 %) |
| Mar 03 2009 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 1.55 | 900 | 1,395 | 59,700 | 60.6 K to 59.7 K (-1.49 %) |
| Mar 03 2009 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 1.54 | 3,700 | 5,698 | 60,600 | 64.3 K to 60.6 K (-5.75 %) |
| Mar 03 2009 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 1.52 | 200 | 304 | 64,300 | 64.5 K to 64.3 K (-0.31 %) |
| Mar 02 2009 | CYTK | CYTOKINETICS INC | WOLFF ANDREW A | SVP Clinical R&D, C ... | Option Exercise | A | 1.85 | 92,083 | 170,354 | 92,083 | |
| Mar 02 2009 | CYTK | CYTOKINETICS INC | WOLFF ANDREW A | SVP Clinical R&D, C ... | Option Exercise | A | 1.85 | 37,917 | 70,146 | 37,917 | |
| Mar 02 2009 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Option Exercise | A | 1.85 | 106,249 | 196,561 | 106,249 | |
| Mar 02 2009 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Option Exercise | A | 1.85 | 43,751 | 80,939 | 43,751 | |
| Mar 02 2009 | CYTK | CYTOKINETICS INC | RABSON MICHAEL | SVP Business Dev/Le ... | Option Exercise | A | 1.85 | 77,916 | 144,145 | 77,916 | |
| Mar 02 2009 | CYTK | CYTOKINETICS INC | RABSON MICHAEL | SVP Business Dev/Le ... | Option Exercise | A | 1.85 | 32,084 | 59,355 | 32,084 | |
| Mar 02 2009 | CYTK | CYTOKINETICS INC | Cragg David | V.P., Human Resourc ... | Option Exercise | A | 1.85 | 49,534 | 91,638 | 49,534 | |
| Mar 02 2009 | CYTK | CYTOKINETICS INC | Cragg David | V.P., Human Resourc ... | Option Exercise | A | 1.85 | 35,466 | 65,612 | 35,466 | |
| Mar 02 2009 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Option Exercise | A | 1.85 | 224,667 | 415,634 | 224,667 | |
| Mar 02 2009 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Option Exercise | A | 1.85 | 50,333 | 93,116 | 50,333 | |
| Mar 02 2009 | CYTK | CYTOKINETICS INC | BARBARI SHARON SURREY | Sr. VP, Finance & C ... | Option Exercise | A | 1.85 | 106,248 | 196,559 | 106,248 | |
| Mar 02 2009 | CYTK | CYTOKINETICS INC | BARBARI SHARON SURREY | Sr. VP, Finance & C ... | Option Exercise | A | 1.85 | 43,752 | 80,941 | 43,752 | |
| Feb 04 2009 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.19 | 500 | 1,095 | 64,500 | 65 K to 64.5 K (-0.77 %) |
| Feb 04 2009 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.17 | 950 | 2,062 | 65,000 | 66 K to 65 K (-1.44 %) |
| Feb 04 2009 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.16 | 300 | 649 | 65,950 | 66.3 K to 66 K (-0.45 %) |
| Feb 04 2009 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.16 | 1,050 | 2,268 | 66,250 | 67.3 K to 66.3 K (-1.56 %) |
| Feb 04 2009 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.15 | 300 | 646 | 67,300 | 67.6 K to 67.3 K (-0.44 %) |
| Feb 04 2009 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.15 | 500 | 1,075 | 67,600 | 68.1 K to 67.6 K (-0.73 %) |
| Feb 04 2009 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.13 | 500 | 1,065 | 68,100 | 68.6 K to 68.1 K (-0.73 %) |
| Feb 04 2009 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.11 | 400 | 844 | 68,600 | 69 K to 68.6 K (-0.58 %) |
| Feb 04 2009 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.11 | 400 | 843 | 69,000 | 69.4 K to 69 K (-0.58 %) |
| Feb 04 2009 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.07 | 100 | 207 | 69,400 | 69.5 K to 69.4 K (-0.14 %) |
| Feb 20 2009 | CYTK | CYTOKINETICS INC | HENDERSON JOHN T | Director | Option Exercise | A | 1.95 | 30,000 | 58,500 | 30,000 | |
| Jan 06 2009 | CYTK | CYTOKINETICS INC | DOW STEPHEN M | Director | Option Exercise | A | 2.85 | 17,543 | 49,998 | 17,543 | |
| Jan 06 2009 | CYTK | CYTOKINETICS INC | HEIDRICH A GRANT III | Director | Option Exercise | A | 2.85 | 17,543 | 49,998 | 17,543 | |
| Jan 05 2009 | CYTK | CYTOKINETICS INC | SPUDICH JAMES A | Director | Option Exercise | A | 2.85 | 17,543 | 49,998 | 17,543 | |
| Jan 06 2009 | CYTK | CYTOKINETICS INC | SCHMERTZLER MICHAEL | Director | Option Exercise | A | 2.85 | 8,771 | 24,997 | 8,771 | |
| Jan 05 2009 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.89 | 1,125 | 3,251 | 69,500 | 70.6 K to 69.5 K (-1.59 %) |
| Jan 05 2009 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.88 | 847 | 2,439 | 70,625 | 71.5 K to 70.6 K (-1.19 %) |
| Jan 05 2009 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.87 | 900 | 2,583 | 71,472 | 72.4 K to 71.5 K (-1.24 %) |
| Jan 05 2009 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.85 | 400 | 1,140 | 72,372 | 72.8 K to 72.4 K (-0.55 %) |
| Jan 05 2009 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.81 | 200 | 562 | 72,772 | 73 K to 72.8 K (-0.27 %) |
| Jan 05 2009 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.80 | 300 | 840 | 72,972 | 73.3 K to 73 K (-0.41 %) |
| Jan 05 2009 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.79 | 128 | 357 | 73,272 | 73.4 K to 73.3 K (-0.17 %) |
| Jan 05 2009 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.78 | 100 | 278 | 73,400 | 73.5 K to 73.4 K (-0.14 %) |
| Jan 05 2009 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.76 | 288 | 795 | 73,500 | 73.8 K to 73.5 K (-0.39 %) |
| Jan 05 2009 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.75 | 312 | 858 | 73,788 | 74.1 K to 73.8 K (-0.42 %) |
| Jan 05 2009 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.71 | 400 | 1,084 | 74,100 | 74.5 K to 74.1 K (-0.54 %) |
| Dec 02 2008 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.39 | 100 | 239 | 74,500 | 74.6 K to 74.5 K (-0.13 %) |
| Dec 02 2008 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.38 | 200 | 476 | 74,600 | 74.8 K to 74.6 K (-0.27 %) |
| Dec 02 2008 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.30 | 100 | 230 | 74,800 | 74.9 K to 74.8 K (-0.13 %) |
| Dec 02 2008 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.29 | 100 | 229 | 74,900 | 75 K to 74.9 K (-0.13 %) |
| Dec 02 2008 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.24 | 460 | 1,030 | 75,000 | 75.5 K to 75 K (-0.61 %) |
| Dec 02 2008 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.22 | 700 | 1,554 | 75,460 | 76.2 K to 75.5 K (-0.92 %) |
| Dec 02 2008 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.14 | 429 | 918 | 76,160 | 76.6 K to 76.2 K (-0.56 %) |
| Dec 02 2008 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.12 | 211 | 447 | 76,589 | 76.8 K to 76.6 K (-0.27 %) |
| Dec 02 2008 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.10 | 1,165 | 2,447 | 76,800 | 78 K to 76.8 K (-1.49 %) |
| Dec 02 2008 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.09 | 155 | 324 | 77,965 | 78.1 K to 78 K (-0.20 %) |
| Dec 02 2008 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.08 | 1,380 | 2,870 | 78,120 | 79.5 K to 78.1 K (-1.74 %) |
| Nov 04 2008 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 3.04 | 100 | 304 | 79,500 | 79.6 K to 79.5 K (-0.13 %) |
| Nov 04 2008 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 3.03 | 300 | 909 | 79,600 | 79.9 K to 79.6 K (-0.38 %) |
| Nov 04 2008 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 3.02 | 300 | 906 | 79,900 | 80.2 K to 79.9 K (-0.37 %) |
| Nov 04 2008 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 3.01 | 100 | 301 | 80,200 | 80.3 K to 80.2 K (-0.12 %) |
| Nov 04 2008 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.99 | 100 | 299 | 80,300 | 80.4 K to 80.3 K (-0.12 %) |
| Nov 04 2008 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.98 | 100 | 298 | 80,400 | 80.5 K to 80.4 K (-0.12 %) |
| Nov 04 2008 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.97 | 100 | 297 | 80,500 | 80.6 K to 80.5 K (-0.12 %) |
| Nov 04 2008 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.95 | 600 | 1,770 | 80,600 | 81.2 K to 80.6 K (-0.74 %) |
| Nov 04 2008 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.94 | 200 | 588 | 81,200 | 81.4 K to 81.2 K (-0.25 %) |
| Nov 04 2008 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.94 | 100 | 294 | 81,400 | 81.5 K to 81.4 K (-0.12 %) |